tert-Butyl 4-(piperazine-1-carbonyl)piperidine-1-carboxylate

Catalog No. :
ACFGPV180
CAS No. :
887587-18-0
Molecular Formula :
C15H27N3O3
Molecular Weight :
297.40

IUPAC Name:tert-butyl 4-(piperazine-1-carbonyl)piperidine-1-carboxylate

tert-Butyl 4-(piperazine-1-carbonyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$75.00Login to see priceIn stockInquiry
1g98%$210.00Login to see priceIn stockIn stock
5g98%$822.00Login to see priceIn stockIn stock
10g98%$1357.00Login to see priceInquiryIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(piperazine-1-carbonyl)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(piperazine-1-carbonyl)piperidine-1-carboxylate
MDL No.MFCD07367784
Molecular FormulaC15H27N3O3
Molecular Weight297.40
SMILESO=C(C1CCN(C(OC(C)(C)C)=O)CC1)N2CCNCC2
InChI KeyYAFVLOOBEOCICL-UHFFFAOYSA-N
Synonym4-(PEPERAZINE-1-CARBONYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;4-(Piperazine-1-carbonyl)-piperidine-1-carboxylic acid tert-butyl ester;1-Boc-4-(piperazine-1-carbonyl)piperidine;1-Piperidinecarboxylic acid, 4-(1-piperazinylcarbonyl)-, 1,1-dimethylethyl ester
CAS No.887587-18-0
PubChem CID21839532

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFGPV180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFGPV180 route product structure diagram
    ACFGPV180887587-18-0 In Stock
Inquiry

2. ACFGPV180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFGPV180 route product structure diagram
    ACFGPV180887587-18-0 In Stock
Inquiry

Comments (0)